We are live on ! Find out more
David Shaw

David Shaw D.E. Shaw & Co

AUM $210B Turnover 26.1%
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+28.4%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$210B
AUM Growth
+$43.9B
Cap. Flow
+$8.31B
Cap. Flow %
3.95%
Top 10 Hldgs %
15.14%
Holding
5,360
New
872
Increased
1,718
Reduced
1,611
Closed
527
Avg Time Held Equity + Options
2.6 years
Top 10 Avg Time Held Equity + Options
0.4 years
Top 20 Avg Time Held Equity + Options
1.2 years
Avg Time Held Equity only
2.6 years
Top 10 Avg Time Held Equity only
1.4 years
Top 20 Avg Time Held Equity only
1.3 years

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$2.17B
2
AVGO icon
Broadcom
AVGO
+$1.53B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
TSM icon
TSMC
TSM
+$928M
5
TXN icon
Texas Instruments
TXN
+$904M

Sector Composition

Rank Sector Weight
1 Miscellaneous 33.7%
2 Technology 18.77%
3 Financials 8.35%
4 Healthcare 7.91%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ATRO icon
926
Astronics
ATRO
$2.58B
$33M 0.02%
406,571
-323,568
-44% -$22.1M
2019 Q1
29 quarters
PEP icon
927
CALL
PepsiCo
PEP
$183B
$33M 0.02%
243,900
-74,200
-23% -$11.1M
2021 Q2
20 quarters
IHI icon
928
iShares US Medical Devices ETF
IHI
$3.56B
$33M 0.02%
667,627
+338,438
+103% +$17.2M
2025 Q3
3 quarters
LYV icon
929
PUT
Live Nation Entertainment
LYV
$40.3B
$33M 0.02%
180,100
+900
+0.5% +$148K
2019 Q3
27 quarters
MP icon
930
PUT
MP Materials
MP
$7.1B
$32.9M 0.02%
587,900
-219,100
-27% -$13.3M
2025 Q2
4 quarters
TAK icon
931
Takeda Pharmaceutical
TAK
$64.9B
$32.9M 0.02%
2,049,467
-553,076
-21% -$9.15M
2025 Q3
3 quarters
TTWO icon
932
PUT
Take-Two Interactive
TTWO
$37.8B
$32.8M 0.02%
131,400
+47,100
+56% +$10.4M
2020 Q2
24 quarters
TEAM icon
933
PUT
Atlassian
TEAM
$55.5B
$32.7M 0.02%
420,800
-303,700
-42% -$24.8M
2018 Q4
30 quarters
HAPN icon
934
Happen Inc
HAPN
$1.63B
$32.7M 0.02%
1,576,086
+806,416
+105% +$13.7M
2020 Q3
23 quarters
APGE icon
935
DELISTED
Apogee Therapeutics
APGE
$32.7M 0.02%
246,086
+187,251
+318% +$16.9M
2024 Q2
8 quarters
PYPL icon
936
CALL
PayPal
PYPL
$48.1B
$32.6M 0.02%
755,500
-40,000
-5% -$1.82M
2017 Q2
36 quarters
ONON icon
937
On Holding
ONON
$10.7B
$32.6M 0.02%
920,124
+869,655
+1,723% +$31.8M
2024 Q3
7 quarters
ENPH icon
938
Enphase Energy
ENPH
$4.06B
$32.6M 0.02%
661,058
-1,667,698
-72% -$76M
2021 Q1
21 quarters
LBTYA icon
939
Liberty Global Class A
LBTYA
$2.64B
$32.5M 0.02%
2,854,713
+1,562,596
+121% +$18.7M
2022 Q1
17 quarters
CDNA icon
940
CareDx
CDNA
$3.69B
$32.4M 0.02%
1,137,660
+262,752
+30% +$5.72M
2018 Q2
32 quarters
MKL icon
941
CALL
Markel Group
MKL
$23.1B
$32.4M 0.02%
16,600
+10,000
+152% +$18.7M
2025 Q4
2 quarters
SCI icon
942
Service Corp International
SCI
$11.3B
$32.4M 0.02%
426,067
+387
+0.1% +$30.3K
2025 Q1
5 quarters
VRSK icon
943
Verisk Analytics
VRSK
$24.6B
$32.3M 0.02%
179,819
-1,020,600
-85% -$180M
2022 Q3
15 quarters
TU icon
944
PUT
Telus
TU
$13.6B
$32.3M 0.02%
3,052,500
– –
2023 Q4
10 quarters
BMY icon
945
Bristol-Myers Squibb
BMY
$125B
$32.2M 0.02%
559,407
+249,569
+81% +$14.3M
2013 Q2
52 quarters
BFAM icon
946
Bright Horizons
BFAM
$3.48B
$32.2M 0.02%
454,593
-55,571
-11% -$4.02M
2025 Q2
4 quarters
EPAC icon
947
Enerpac Tool Group
EPAC
$1.82B
$32.1M 0.02%
896,260
+181,148
+25% +$6.35M
2022 Q2
16 quarters
STM icon
948
STMicroelectronics
STM
$42.9B
$32.1M 0.02%
428,683
+378,431
+753% +$22.8M
2026 Q1
1 quarter
UHAL icon
949
U-Haul Holding Co
UHAL
$10.9B
$32.1M 0.02%
489,815
+197,537
+68% +$10.8M
2021 Q1
21 quarters
NEO icon
950
NeoGenomics
NEO
$2.22B
$32M 0.02%
2,194,758
-1,969,425
-47% -$19M
2025 Q2
4 quarters

Similar funds

David Shaw's Q2 2026 Portfolio in Review

As of Q2 2026, David Shaw held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

David Shaw deployed $8.31B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.

By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 30% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.

  • David Shaw's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
  • David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.6B increase.
  • David Shaw's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
  • David Shaw fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
  • David Shaw's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
  • David Shaw opened 872 new positions and closed 527 in Q2 2026.
  • David Shaw's portfolio value rose 26% quarter-over-quarter to $210B.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.